Last reviewed · How we verify

NCT05857488

Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at UVa

Terminated NA Results posted Last updated 8 August 2025
What this trial tests

NA trial testing Transnasal introduction tube in Healthy in 1 participant. Terminated before completion.

Timeline
1 January 2022
Primary endpoint
17 June 2022
17 June 2022

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment1
Start date1 January 2022
Primary completion17 June 2022
Estimated completion17 June 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

Adults 6 Months to 48 Months, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Ability for Unsedated Infant Subjects to Tolerate the Device Primary · Approximate 90 minute study visit

Can the unsedated infant subjects tolerate the administration of the device with minimal discomfort?

GroupValue95% CI
Trans Nasal Endomicroscopy Imaging1

Sponsor's own description

The purpose of this study is to demonstrate the feasibility of using the transnasal endomicroscopy (TNE) platform, using intestinal potential difference (IPD) and microbiome brush to evaluate the intestine of unsedated infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05857488.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing